Clinical Trial Update: A Study of JMT101 in Patients With Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for JMT101 in patients with metastatic colorectal cancer is currently listed as unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• JMT101

Snippet

Sponsor: Shanghai JMT-Bio Inc. | Conditions: Metastatic Colorectal Cancer (mCRC) | Phase 2 | Status: UNKNOWN